Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
Clinical trial NCT06551207 · RECRUITING
Trial details
- NCT number
- NCT06551207
- Sponsor
- Liu Huang
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2026-12-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.